5,6-Dimethylxantheonone-4-acetic acid

Independent reference data for 5,6-Dimethylxantheonone-4-acetic acid (CAS 117570-53-3), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Investigated for use/treatment in solid tumors, lung cancer, ovarian cancer, and prostate cancer.Substances that inhibit or prevent the proliferation of NEOPLASMS.

Synonyms and trade names

Vadimezan; 117570-53-3; DMXAA; 5,6-Mexaa; 2-(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid; 5,6-Dimethylxanthenone-4-acetic acid; AS-1404; ASA-404; ASA404; NSC-640488; 9H-Xanthene-4-acetic acid, 5,6-dimethyl-9-oxo-; 5,6-dimethylxanthenoneacetic acid; Dimethyloxoxanthene acetic acid; 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid; vadimezanum; NSC 640488

GHS hazard classification

Reported hazard statements	H302 (100%), H400 (97.5%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

H400 (97.5%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]

What the public record says

5,6-Dimethylxantheonone-4-acetic acid · CAS 117570-53-3 · C17H14O4. UNII 0829J8133H.

Source: PubChem / Wikidata; the batch COA governs where values differ.